Giovanni Martino
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Giovanni Martino has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Alberto Polimeni
Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy
4 shared publications - Antonio Curcio
Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy
3 shared publications - Ciro Indolfi
Italian Federation of Cardiology, Roma, Italy
3 shared publications Antonio Curcio
Department of Pharmacy, Health Sciences and Nutrition, University of Calabria, Arcavacata di Rende, Italy
2 shared publications- Carmen Spaccarotella
Division of Cardiology, Department of Advanced Biomedical Sciences, Federico II University, 80134 Naples, Italy
2 shared publications - Francesco Greco
Division of Interventional Cardiology, Annunziata Hospital, 87100 Cosenza, Italy
2 shared publications
Latest Publications
- Open Access
- 19 February 2026
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 5 (4) , 104391
Mechanism- and Physiology-Guided Drug-Coated Balloon-Only Percutaneous Coronary Intervention in Complex Multivessel Coronary Artery Disease: Insights From IVUS and vFFR
- 19 February 2026
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 5 (4) , 104391
Open AccessMechanism- and Physiology-Guided Drug-Coated Balloon-Only Percutaneous Coronary Intervention in Complex Multivessel Coronary Artery Disease: Insights From IVUS and vFFR
- Open Access
- 1 October 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 9 (10) , ytaf524
Murray law-based quantitative flow ratio for optimizing revascularization in anterior ST-elevation myocardial infarction due to spontaneous coronary artery dissection: a case report
Background: Spontaneous coronary artery dissection (SCAD) is a rare, non-atherosclerotic cause of acute coronary syndrome (ACS) characterized by compression of the coronary true lumen by a blood-filled false lumen. Conservative management is recommended for most cases, with percutaneous coronary intervention (PCI) reserved for patients with significant ischaemia, reduced coronary blood flow, or haemodynamic instability. Percutaneous coronary intervention in SCAD is challenging, with a high complication rate, and the optimal approach remains debated. Case summary: We describe a 43-year-old woman presenting with acute retrosternal chest pain and ST-segment elevation consistent with an anterior ST-elevation myocardial infarction. The patient medical history included hypertension, smoking, recent hormonal therapy, and prednisone use. Emergent coronary angiography revealed a type IIb SCAD in the mid-left anterior descending artery with vessel occlusion. Plain balloon angioplasty successfully restored good antegrade flow (TIMI 3), deferring the decision of stent implantation on follow-up coronary angiography. Murray law-based quantitative flow ratio (μQFR) revealed a haemodynamically non-significant lesion at 10 days of follow-up. The patient remained stable, demonstrating recovery of myocardial function and no recurrent symptoms at 12-months of follow-up. Discussion: Murray law-based quantitative flow ratio offers a non-invasive tool to guide revascularization in SCAD patients. While promising, evidence for μQFR in SCAD is lacking, highlighting the need for further studies to validate its utility in this context.
- 1 October 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 9 (10) , ytaf524
Open AccessMurray law-based quantitative flow ratio for optimizing revascularization in anterior ST-elevation myocardial infarction due to spontaneous coronary artery dissection: a case report
Background: Spontaneous coronary artery dissection (SCAD) is a rare, non-atherosclerotic cause of acute coronary syndrome (ACS) characterized by compression of the coronary true lumen by a blood-filled false lumen. Conservative management is recommended for most cases, with percutaneous coronary intervention (PCI) reserved for patients with significant ischaemia, reduced coronary blood flow, or haemodynamic instability. Percutaneous coronary intervention in SCAD is challenging, with a high complication rate, and the optimal approach remains debated. Case summary: We describe a 43-year-old woman presenting with acute retrosternal chest pain and ST-segment elevation consistent with an anterior ST-elevation myocardial infarction. The patient medical history included hypertension, smoking, recent hormonal therapy, and prednisone use. Emergent coronary angiography revealed a type IIb SCAD in the mid-left anterior descending artery with vessel occlusion. Plain balloon angioplasty successfully restored good antegrade flow (TIMI 3), deferring the decision of stent implantation on follow-up coronary angiography. Murray law-based quantitative flow ratio (μQFR) revealed a haemodynamically non-significant lesion at 10 days of follow-up. The patient remained stable, demonstrating recovery of myocardial function and no recurrent symptoms at 12-months of follow-up. Discussion: Murray law-based quantitative flow ratio offers a non-invasive tool to guide revascularization in SCAD patients. While promising, evidence for μQFR in SCAD is lacking, highlighting the need for further studies to validate its utility in this context.
- Open Access
- 25 January 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (2) , 177
The Role of Circulating Biomarkers in Patients with Coronary Microvascular Disease
Coronary microvascular disease (CMD) comprises a spectrum of conditions characterized by the functional and structural abnormalities of coronary microcirculation, affecting vessels typically smaller than 500 μm. Despite its clinical significance as a contributor to myocardial ischemia, CMD frequently remains underdiagnosed due to the limitations of current diagnostic approaches. Invasive testing, including coronary reactivity assessment, is considered the gold standard, but it is resource-intensive and not always accessible. Non-invasive methods, such as positron emission tomography (PET) and transthoracic Doppler echocardiography (TTDE), offer alternatives but are limited by varying accuracy and accessibility. Amid these diagnostic challenges, there is increasing interest in circulating biomarkers as adjuncts in CMD evaluation. Biomarkers associated with endothelial dysfunction, inflammation, and oxidative stress, detectable through routine blood tests, may assist in CMD diagnosis, risk stratification, and therapeutic monitoring. These biomarkers can offer insights into CMD pathogenesis and enable early, non-invasive screening to identify patients who may benefit from more invasive investigations. This narrative review examines studies assessing biomarkers in CMD patients with diagnoses confirmed through invasive techniques. Our objective is to focus on circulating biomarkers linked to the invasive evaluation of coronary microcirculation, aiming to advance the understanding of the underlying mechanisms of this prevalent condition and enhance diagnostic accuracy and the clinical management of affected patients.
- 25 January 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (2) , 177
Open AccessThe Role of Circulating Biomarkers in Patients with Coronary Microvascular Disease
Coronary microvascular disease (CMD) comprises a spectrum of conditions characterized by the functional and structural abnormalities of coronary microcirculation, affecting vessels typically smaller than 500 μm. Despite its clinical significance as a contributor to myocardial ischemia, CMD frequently remains underdiagnosed due to the limitations of current diagnostic approaches. Invasive testing, including coronary reactivity assessment, is considered the gold standard, but it is resource-intensive and not always accessible. Non-invasive methods, such as positron emission tomography (PET) and transthoracic Doppler echocardiography (TTDE), offer alternatives but are limited by varying accuracy and accessibility. Amid these diagnostic challenges, there is increasing interest in circulating biomarkers as adjuncts in CMD evaluation. Biomarkers associated with endothelial dysfunction, inflammation, and oxidative stress, detectable through routine blood tests, may assist in CMD diagnosis, risk stratification, and therapeutic monitoring. These biomarkers can offer insights into CMD pathogenesis and enable early, non-invasive screening to identify patients who may benefit from more invasive investigations. This narrative review examines studies assessing biomarkers in CMD patients with diagnoses confirmed through invasive techniques. Our objective is to focus on circulating biomarkers linked to the invasive evaluation of coronary microcirculation, aiming to advance the understanding of the underlying mechanisms of this prevalent condition and enhance diagnostic accuracy and the clinical management of affected patients.
- Open Access
- 9 January 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (2) , 355
Physiology-Versus Angiography-Guided Complete Coronary Revascularization in STEMI Patients with Multivessel Disease: A Network Meta-Analysis
Background: In patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease (MVD), complete revascularization (CR) is recommended over culprit-only PCI to reduce adverse cardiovascular outcomes. However, the optimal strategy for CR, whether angiography (Angio)-guided or physiology-guided, remains uncertain. Methods: This network meta-analysis included 14 randomized controlled trials (RCTs) with 11,568 patients to compare the efficacy of angio-guided CR, physiology-guided CR, and culprit-only PCI in reducing major adverse cardiovascular events (MACE), all-cause mortality, recurrent myocardial infarction (MI), cardiovascular (CV) death, and unplanned revascularization. The frequentist and Bayesian approaches were applied to assess the effectiveness of each strategy. Results: The pairwise meta-analysis showed that angio-guided CR showed superior efficacy, significantly reducing MACE (OR = 0.44; 95% CI: 0.37–0.52), recurrent myocardial infarction, and unplanned revascularization compared to culprit-only PCI. Physiology-guided CR also reduced MACE (OR = 0.64, 95% CI: 0.45–0.91) and unplanned revascularization. The network metanalysis showed that CV death was lower in the physiology-guided CR group (OR 0.56; 95% CI 0.25–1.05), suggesting a protective effect, but the difference did not reach statistical significance. Furthermore, physiology-guided CR was not significantly better than angio-guided CR in most outcomes. Conclusions: Angio-guided CR appears to provide the best overall outcomes for patients with STEMI and MVD, outperforming physiology-guided CR in most endpoints. Further large-scale trials are needed to clarify the relative efficacy of angio-guided CR and physiology-guided CR in this patient population.
- 9 January 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (2) , 355
Open AccessPhysiology-Versus Angiography-Guided Complete Coronary Revascularization in STEMI Patients with Multivessel Disease: A Network Meta-Analysis
Background: In patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease (MVD), complete revascularization (CR) is recommended over culprit-only PCI to reduce adverse cardiovascular outcomes. However, the optimal strategy for CR, whether angiography (Angio)-guided or physiology-guided, remains uncertain. Methods: This network meta-analysis included 14 randomized controlled trials (RCTs) with 11,568 patients to compare the efficacy of angio-guided CR, physiology-guided CR, and culprit-only PCI in reducing major adverse cardiovascular events (MACE), all-cause mortality, recurrent myocardial infarction (MI), cardiovascular (CV) death, and unplanned revascularization. The frequentist and Bayesian approaches were applied to assess the effectiveness of each strategy. Results: The pairwise meta-analysis showed that angio-guided CR showed superior efficacy, significantly reducing MACE (OR = 0.44; 95% CI: 0.37–0.52), recurrent myocardial infarction, and unplanned revascularization compared to culprit-only PCI. Physiology-guided CR also reduced MACE (OR = 0.64, 95% CI: 0.45–0.91) and unplanned revascularization. The network metanalysis showed that CV death was lower in the physiology-guided CR group (OR 0.56; 95% CI 0.25–1.05), suggesting a protective effect, but the difference did not reach statistical significance. Furthermore, physiology-guided CR was not significantly better than angio-guided CR in most outcomes. Conclusions: Angio-guided CR appears to provide the best overall outcomes for patients with STEMI and MVD, outperforming physiology-guided CR in most endpoints. Further large-scale trials are needed to clarify the relative efficacy of angio-guided CR and physiology-guided CR in this patient population.
- Open Access
- 8 August 2024
- Published by Heighten Science Publications Corporation in Journal of Cardiology and Cardiovascular Medicine
- Vol. 9 (2) , 110-115
Imaging Challenge in Recurrent Spontaneous Coronary Artery Dissection (SCAD): A Case Report
Spontaneous Coronary Artery Dissection (SCAD) represents a significant cause of acute coronary syndrome (ACS) in patient populations with low-risk cardiovascular profiles and, therefore can be sometimes underdiagnosed. On the other hand, it often preserves the typical clinical presentation of ACS which makes coronary artery angiography (CAG) execution mandatory. A 62-year-old woman with a history of recurrent SCAD presented to the emergency department for a new episode of acute chest pain with troponin elevation. CAG revealed an ambiguous angiography image suggesting a sub-occlusive type 2 SCAD involving the distal segment of the left circumflex artery. The patient was managed conservatively due to the absence of ongoing ischemia or hemodynamic instability. At the seven-day follow-up, a computed tomography coronary angiography (CTCA) was performed to better assess SCAD and detect concomitant associated arteriopathies. Optimized medical therapy was prescribed at the discharge and at one-month follow-up, no recurrence of symptoms was referred.
- 8 August 2024
- Published by Heighten Science Publications Corporation in Journal of Cardiology and Cardiovascular Medicine
- Vol. 9 (2) , 110-115
Open AccessImaging Challenge in Recurrent Spontaneous Coronary Artery Dissection (SCAD): A Case Report
Spontaneous Coronary Artery Dissection (SCAD) represents a significant cause of acute coronary syndrome (ACS) in patient populations with low-risk cardiovascular profiles and, therefore can be sometimes underdiagnosed. On the other hand, it often preserves the typical clinical presentation of ACS which makes coronary artery angiography (CAG) execution mandatory. A 62-year-old woman with a history of recurrent SCAD presented to the emergency department for a new episode of acute chest pain with troponin elevation. CAG revealed an ambiguous angiography image suggesting a sub-occlusive type 2 SCAD involving the distal segment of the left circumflex artery. The patient was managed conservatively due to the absence of ongoing ischemia or hemodynamic instability. At the seven-day follow-up, a computed tomography coronary angiography (CTCA) was performed to better assess SCAD and detect concomitant associated arteriopathies. Optimized medical therapy was prescribed at the discharge and at one-month follow-up, no recurrence of symptoms was referred.